Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1979 2
1980 3
1981 2
1982 6
1983 3
1984 5
1985 9
1986 5
1987 7
1988 8
1989 5
1990 16
1991 16
1992 25
1993 32
1994 27
1995 26
1996 36
1997 43
1998 41
1999 53
2000 66
2001 86
2002 106
2003 137
2004 170
2005 246
2006 311
2007 295
2008 378
2009 456
2010 518
2011 660
2012 770
2013 936
2014 1089
2015 1259
2016 1304
2017 1454
2018 1630
2019 1809
2020 2161
2021 497
Text availability
Article attribute
Article type
Publication date

Search Results

14,914 results
Results by year
Filters applied: . Clear all
Page 1
An SHR-SCR module specifies legume cortical cell fate to enable nodulation.
Dong W, Zhu Y, Chang H, Wang C, Yang J, Shi J, Gao J, Yang W, Lan L, Wang Y, Zhang X, Dai H, Miao Y, Xu L, He Z, Song C, Wu S, Wang D, Yu N, Wang E. Dong W, et al. Among authors: shi j. Nature. 2021 Jan;589(7843):586-590. doi: 10.1038/s41586-020-3016-z. Epub 2020 Dec 9. Nature. 2021. PMID: 33299183
ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression.
Lan X, Ren R, Feng R, Ly LC, Lan Y, Zhang Z, Aboreden N, Qin K, Horton JR, Grevet JD, Mayuranathan T, Abdulmalik O, Keller CA, Giardine B, Hardison RC, Crossley M, Weiss MJ, Cheng X, Shi J, Blobel GA. Lan X, et al. Among authors: shi j. Mol Cell. 2021 Jan 21;81(2):239-254.e8. doi: 10.1016/j.molcel.2020.11.006. Epub 2020 Dec 9. Mol Cell. 2021. PMID: 33301730
RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC).
Shi Y, Wu L, Yu X, Xing P, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y. Shi Y, et al. Among authors: shi j. Ann Oncol. 2020 Dec;31 Suppl 7:S1428. doi: 10.1016/j.annonc.2020.10.517. Epub 2020 Dec 13. Ann Oncol. 2020. PMID: 33517977
Management of aggressive fibromatosis.
Zhang Z, Shi J, Yang T, Liu T, Zhang K. Zhang Z, et al. Among authors: shi j. Oncol Lett. 2021 Jan;21(1):43. doi: 10.3892/ol.2020.12304. Epub 2020 Nov 17. Oncol Lett. 2021. PMID: 33262835 Free PMC article. Review.
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Zhang T, Shi W, Zou J; CameL Study Group. Zhou C, et al. Among authors: shi j. Lancet Respir Med. 2020 Dec 18:S2213-2600(20)30365-9. doi: 10.1016/S2213-2600(20)30365-9. Online ahead of print. Lancet Respir Med. 2020. PMID: 33347829
The development of small-molecule inhibitors targeting CD47.
Yu WB, Ye ZH, Chen X, Shi JJ, Lu JJ. Yu WB, et al. Among authors: shi jj. Drug Discov Today. 2020 Nov 13:S1359-6446(20)30468-2. doi: 10.1016/j.drudis.2020.11.003. Online ahead of print. Drug Discov Today. 2020. PMID: 33197622 Review.
14,914 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page